141 related articles for article (PubMed ID: 37909870)
1. Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+ pack-year history: A systematic review.
Kondo KK; Rahman B; Ayers CK; Relevo R; Griffin JC; Halpern MT
CA Cancer J Clin; 2024; 74(1):84-114. PubMed ID: 37909870
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer risk by years since quitting in 30+ pack year smokers.
Pinsky PF; Zhu CS; Kramer BS
J Med Screen; 2015 Sep; 22(3):151-7. PubMed ID: 25926339
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Screening for lung cancer: 2023 guideline update from the American Cancer Society.
Wolf AMD; Oeffinger KC; Shih TY; Walter LC; Church TR; Fontham ETH; Elkin EB; Etzioni RD; Guerra CE; Perkins RB; Kondo KK; Kratzer TB; Manassaram-Baptiste D; Dahut WL; Smith RA
CA Cancer J Clin; 2024; 74(1):50-81. PubMed ID: 37909877
[TBL] [Abstract][Full Text] [Related]
5. Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study.
Tindle HA; Stevenson Duncan M; Greevy RA; Vasan RS; Kundu S; Massion PP; Freiberg MS
J Natl Cancer Inst; 2018 Nov; 110(11):1201-1207. PubMed ID: 29788259
[TBL] [Abstract][Full Text] [Related]
6. Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold: A simulation modeling study.
Meza R; Cao P; de Nijs K; Jeon J; Smith RA; Ten Haaf K; de Koning H
Cancer; 2024 Jan; 130(2):244-255. PubMed ID: 37909874
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
8. Reexamining Rates of Decline in Lung Cancer Risk after Smoking Cessation. A Meta-analysis.
Reitsma M; Kendrick P; Anderson J; Arian N; Feldman R; Gakidou E; Gupta V
Ann Am Thorac Soc; 2020 Sep; 17(9):1126-1132. PubMed ID: 32603182
[No Abstract] [Full Text] [Related]
9. Assessment of Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended.
Faselis C; Nations JA; Morgan CJ; Antevil J; Roseman JM; Zhang S; Fonarow GC; Sheriff HM; Trachiotis GD; Allman RM; Deedwania P; Zeng-Trietler Q; Taub DD; Ahmed AA; Howard G; Ahmed A
JAMA Oncol; 2022 Oct; 8(10):1428-1437. PubMed ID: 35900734
[TBL] [Abstract][Full Text] [Related]
10. Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility.
Landy R; Gomez I; Caverly TJ; Kawamoto K; Rivera MP; Robbins HA; Young CD; Chaturvedi AK; Cheung LC; Katki HA
JAMA Netw Open; 2023 Sep; 6(9):e2331155. PubMed ID: 37721755
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines.
Pinheiro LC; Groner L; Soroka O; Prosper AE; Jack K; Tamimi RM; Safford M; Phillips E
JAMA Netw Open; 2022 Sep; 5(9):e2229741. PubMed ID: 36053535
[TBL] [Abstract][Full Text] [Related]
12. Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US.
Choi E; Ding VY; Luo SJ; Ten Haaf K; Wu JT; Aredo JV; Wilkens LR; Freedman ND; Backhus LM; Leung AN; Meza R; Lui NS; Haiman CA; Park SL; Le Marchand L; Neal JW; Cheng I; Wakelee HA; Tammemägi MC; Han SS
JAMA Oncol; 2023 Dec; 9(12):1640-1648. PubMed ID: 37883107
[TBL] [Abstract][Full Text] [Related]
13. Absolute lung cancer risk increases among individuals with >15 quit-years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines.
Landy R; Cheung LC; Young CD; Chaturvedi AK; Katki HA
Cancer; 2024 Jan; 130(2):201-215. PubMed ID: 37909885
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.
Reese TJ; Schlechter CR; Potter LN; Kawamoto K; Del Fiol G; Lam CY; Wetter DW
JAMA Netw Open; 2021 Jan; 4(1):e2033769. PubMed ID: 33433600
[TBL] [Abstract][Full Text] [Related]
15. Potential Impact of Criteria Modifications on Race and Sex Disparities in Eligibility for Lung Cancer Screening.
Smeltzer MP; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Ramos R; Qureshi T; Mukhopadhyay A; Ray MA; Osarogiagbon RU
J Thorac Oncol; 2023 Feb; 18(2):158-168. PubMed ID: 36208717
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]